文献速递乳腺癌放疗放疗物理与技术

泊松线性二次肿瘤控制概率模型在乳腺放疗中的验证

Poisson Linear-Quadratic Tumor Control Probability Model Validation in Micro- and Macroscopic Breast Cancer Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-11-23

本研究利用START A/B、FAST-Forward及EBCTCG等乳腺癌放疗数据集,验证了纳入肿瘤体积异质性、患者间放射敏感性差异和治疗时间效应的泊松线性二次肿瘤控制概率模型。模型能重现辅助放疗和单纯放疗的5年局部控制率,估计术后残留克隆源性细胞数为125,总治疗时间对局部区域复发的影响为0.58 Gy/d。模拟显示术前立体定向方案对大肿瘤的局部控制率随肿瘤增大而下降。

要点

  • 模型能重现辅助和单纯放疗的5年局部控制率。
  • 术后残留克隆源性细胞数估计为125。
  • 总治疗时间对局部区域复发的影响为0.58 Gy/d,与START试验的0.60 Gy/d接近。

核心结论

  • 纳入肿瘤大小异质性、放射敏感性差异和时间效应的泊松线性二次群体肿瘤控制概率模型,为预测乳腺癌放疗局部控制提供了稳健框架。

研究设计与样本

  • 利用START A/B、FAST-Forward和EBCTCG研究发表的局部控制数据,拟合模型参数,包括α、β、α/β、σα、肿瘤体积缩放和指数时间至失败。

主要发现

  • 模型重现了辅助放疗和单纯放疗场景下的5年局部控制结局。
  • 估计术后残留克隆源性细胞数为125。
  • 计算的总治疗时间对局部区域复发的影响为0.58 Gy/d,与START试验的0.60 Gy/d估计接近。
  • 模拟显示术前立体定向 schedule 的局部控制率强烈依赖肿瘤大小:5 mm直径(T1a)肿瘤单次23 Gy预测局部控制率>99.9%,10次方案约98%;10 mm直径肿瘤单次治疗维持>98%局部控制率。
  • 随着肿瘤增大局部控制率下降,对于直径>4 cm的肿瘤,没有评估的方案达到>90%局部控制率。

关键数值与推荐

  • 术后残留克隆源性细胞数估计值为125。
  • 总治疗时间对局部区域复发的影响计算值为0.58 Gy/d。
  • START试验的总治疗时间效应估计值为0.60 Gy/d。
  • 5 mm直径(T1a)肿瘤单次23 Gy预测局部控制率>99.9%,10次方案约98%。
  • 10 mm直径肿瘤单次治疗维持>98%局部控制率。

临床怎么用

  • 该模型可用于根据个体患者和肿瘤特征调整剂量方案,有望改善局部控制率并优化治疗策略。
  • 需在更大数据集进一步验证后,该模型可能成为 tailoring 剂量方案的有价值工具。

局限性

  • 模型需在更大数据集中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To validate a mechanistic Poissonian linear-quadratic tumor control probability model that incorporates tumor-volume heterogeneity, interpatient radiosensitivity variability, and treatment time effects using published breast cancer radiation therapy (RT) data sets. METHODS AND MATERIALS: Local control (LC) data were obtained from the START A/B, FAST-Forward, and Early Breast Cancer Trialists' Collaborative Group studies. To address diverse scenarios, we combined data on the additive effect of adjuvant RT with outcomes from RT-alone treatments. We fitted the model parameters [α, β, α/β, σα (interpatient heterogeneity), tumor volume scaling, and exponential time-to-failure] against the observed LC rates. We quantified the effect of overall treatment duration on locoregional recurrence and estimated the residual clonogen count after surgery. We also predicted in-breast recurrence rates for various tumor sizes for neoadjuvant tumor-directed RT dose-fractionation schemes. RESULTS: The model reproduced 5-year LC outcomes across both adjuvant and RT-alone settings. The estimated residual clonogen count after surgery was 125. The calculated effect of overall treatment time for locoregional recurrence was 0.58 Gy/d, closely aligning with the 0.60 Gy/d estimate from the START trials. Simulations showed strong tumor-size dependence for preoperative stereotactic schedules: for a 5-mm diameter (T1a) tumor, the model predicted that a single 23-Gy fraction would result in >99.9% LC, whereas a 10-fraction regimen would yield ∼98% LC. For a 10-mm diameter tumor, single-fraction treatments maintained >98% LC. Control declined with increasing size, and no evaluated regimen achieved >90% LC for tumors >4 cm in diameter. CONCLUSIONS: By incorporating tumor size heterogeneity, radiosensitivity variability, and time effect, the Poissonian linear-quadratic-based population tumor control probability model provides a robust framework for predicting LC in breast cancer RT. With further validation in larger data sets, this model could become a valuable tool to tailor dose regimens to individual patient and tumor characteristics, potentially improving LC rates and optimizing treatment strategies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Unterkirhers S, Erni S, Gruber G, et al. Poisson Linear-Quadratic Tumor Control Probability Model Validation in Micro- and Macroscopic Breast Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025. PMID: 41290049. doi:10.1016/j.ijrobp.2025.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。